Anthropic launched its AI for Science program offering free API credits for drug discovery research, followed by Claude for Life Sciences and a $400M

Anthropic's Claude Science is an AI workbench that unifies a scientist's tools and lets agents run the analysis, with a reviewer agent to check it.

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, those doing research at pharma companies.

The launch is part of Anthropic's life sciences and healthcare initiative, which the IPO-bound company has been developing since October 2025.

The company is doubling down on AI for science.